Can You Read These Rxs?

Published Online: Wednesday, April 16, 2014
Follow Pharmacy_Times:


Rx 1

It’s no wonder that pharmacist Charles Deboyace, RPh, of Price Chopper Pharmacy in Oneonta, New York, could not decipher this messy Rx—the physician’s order is for a medication strength that is not commercially available.
Can you figure out what’s being prescribed?



Rx 2
Pharmacy Manager Khanh Pham and Senior Pharmacy Technicians Katy McGroarty and Joseph Palang of Walgreens Pharmacy #6310 in Las Vegas, Nevada, all tried to interpret this cramped writing. To clarify the drug and directions, they finally had to call the prescriber’s office.
Can you read this Rx?

Have eye-straining, baffling prescriptions? Send them to us at Pharmacy Times--now via email as well as regular mail!
Along with a clean photocopy or scanne image of the prescription itself, your submission must include: (1) the name of your institution and its location; (2) your name and title (PharmD, RPh, Pharm Tech); (3) the correct name of the drug(s), strength, and dosing requirements; and (4) your telephone number. Please e-mail scanned Rxs to kmckay@pharmacytimes.com or mail your submissions to: Can You Read These Rxs?, Pharmacy Times, 666 Plainsboro Road, Suite 300, Plainsboro, NJ 08536.


Related Articles
Like lightening that strikes the same place twice, an armed thief successfully robbed the same pharmacy in a 1-week time frame.
The Walgreens Flu Index™ is a weekly report developed to provide state- and market-specific information regarding flu activity, and ranking of those experiencing the highest incidences of influenza across the country. With the ability to generate hyper-local data that’s as specific as a single zip code, the Index aims to drive consumer awareness and prevention within communities, while also serving as a valuable resource for health departments, media and others at the local level.
A Walgreens pharmacist in Rutland, Vermont, was convicted on 2 misdemeanor charges of unlawful possession of narcotics.
Walgreens today announced that, effective immediately, Walgreens Infusion Services will serve as a limited network home infusion provider for BLINCYTO™ (blinatumomab), a therapy for the treatment of patients with Philadelphia chromosome-negative (Ph-) relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL). BLINCYTO™ can now be obtained through and administered by Walgreens Infusion Services.
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$